C Darrell Jennings
Overview
Explore the profile of C Darrell Jennings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forster D, Lin N, Levens J, Stone R, Berry S, Durbin E, et al.
Am J Infect Control
. 2021 Aug;
49(9):1158-1161.
PMID: 34454683
Background: The purpose of this study was to assess the occupational SARS-CoV-2 infection risk among health care workers (HCW) at University of Kentucky HealthCare (UKHC) by evaluating the prevalence of...
2.
Kolesar J, Gayheart T, Poston L, Monday E, Forster D, Belcher E, et al.
medRxiv
. 2020 Dec;
PMID: 33330888
Background: Following COVID-19 exposure, the CDC recommends a 10-14 day quarantine for asymptomatic individuals and more recently a 7 day quarantine with a negative PCR test. We performed a university-based...
3.
Strattan E, Palaniyandi S, Kumari R, Du J, Hakim N, Huang T, et al.
Front Immunol
. 2019 Nov;
10:2470.
PMID: 31681336
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is often used to treat acute leukemia or defects of hematopoiesis. Its widespread use is hampered by graft-vs.-host disease (GVHD), which has high morbidity...
4.
Lutz C, Al-Attar A, May J, Jennings C
Transplantation
. 2014 Jun;
98(8):853-6.
PMID: 24914571
Background: Alloantibodies to the Bw4 epitope are known to be heterogeneous, but it is widely assumed that anti-Bw4 alloantibodies arise only in individuals who do not express a Bw4 epitope....
5.
Lutz C, Macivor D, Rayapati P, Jennings C
Am Surg
. 2014 Mar;
80(3):E97-8.
PMID: 24666858
No abstract available.
6.
Brandon J, Jennings C, Kaplan A, Bryson J
Cytokine
. 2013 Feb;
61(3):732-5.
PMID: 23402791
Syngeneic graft-versus-host disease (SGVHD), a chronic inflammatory disease, develops following irradiation, syngeneic bone marrow transplantation (BMT) and treatment with the immunosuppressive agent cyclosporine A (CsA). We have shown that TH1...
7.
Frantz A, Bruno M, Rogier E, Tuna H, Cohen D, Bondada S, et al.
Inflamm Bowel Dis
. 2012 Oct;
18(11):2138-48.
PMID: 23070952
Background: The pathogenesis of inflammatory bowel disease (IBD) is complex and the need to identify molecular biomarkers is critical. Epithelial cells play a central role in maintaining intestinal homeostasis. We...
8.
Bryson J, Brandon J, Jennings C, Kaplan A
Chimerism
. 2011 Sep;
2(2):58-60.
PMID: 21912721
Murine syngeneic graft-versus-host disease (SGVHD) results in chronic colon and liver inflammation following syngeneic bone marrow transplantation (BMT) and treatment with the calcineurin inhibitor, cyclosporine A (CsA). SGVHD was initially...
9.
Moirangthem V, Katz W, Su W, Choi E, Dingle R, Zeigler G, et al.
Exp Toxicol Pathol
. 2011 Jul;
65(1-2):61-7.
PMID: 21726989
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a representative of a large group of polyhalogenated aromatic hydrocarbons that are widespread environmental contaminants. Administration of TCDD to laboratory animals or cultured cells results in a...
10.
Brandon J, Jennings C, Kaplan A, Bryson J
J Immunol
. 2011 Feb;
186(6):3726-34.
PMID: 21296982
Murine syngeneic graft-versus-host disease (SGVHD) initiates colon and liver inflammation following lethal irradiation, reconstitution with syngeneic bone marrow transplantation, and therapy with the immunosuppressive agent cyclosporine A. Previous studies have...